DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR CRISABOROLE
» See Plans and Pricing
All Clinical Trials for Crisaborole
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT03233529 | Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis | Not yet recruiting | Pfizer | Phase 2 | 2017-07-31 | This study is being conducted to characterize the mechanism of action of crisaborole ointment 2%, by evaluation of efficacy and changes in key skin biomarkers in atopic dermatitis (AD) lesions treated with crisaborole ointment 2% over vehicle, in subjects with mild to moderate AD. Two identified AD skin lesions for each subject will be treated for the first 15 days, one with crisaborole ointment 2% and one with vehicle, in a blinded manner, and biopsies for biomarker analysis will be performed on the lesions. Following completion of the blinded treatment period, subjects will start the 28 day open label period during which all AD affected skin lesions will be treated with crisaborole ointment 2% twice daily. |
| NCT03260595 | A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatit | Not yet recruiting | Pfizer | Phase 1 | 2017-09-24 | This is a Phase 1 parallel-cohort study of crisaborole ointment 2% to evaluate the skin irritation potential in adult Japanese healthy subjects in Cohort 1, and to evaluate the safety, tolerability and PK in adult Japanese subjects with mild to moderate AD in Cohort 2. |
| NCT03351114 | Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea | Not yet recruiting | Pfizer | Phase 2 | 2018-01-01 | This is a pilot study to determine the safety and clinical efficacy of crisaborole 2% ointment in the treatment of morphea. |
| NCT03351114 | Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea | Not yet recruiting | Duke University | Phase 2 | 2018-01-01 | This is a pilot study to determine the safety and clinical efficacy of crisaborole 2% ointment in the treatment of morphea. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Crisaborole
Condition Name
Condition MeSH
Clinical Trial Locations for Crisaborole
Trials by Country
Clinical Trial Progress for Crisaborole
Clinical Trial Phase
Clinical Trial Sponsors for Crisaborole
Sponsor Name
